Peripheral blood mononuclear cells (PBMCs) collected on day 1 post-tumor challenge or splenocytes collected at end-of-life from control mice and surviving mIGV-001 treated mice were used in FluoroSpot or ELISpot assays to measure IFN-γ production by T cells. PBMCs were stimulated using tumor lysate-pulsed DCs and splenocytes were incubated with major histocompatibility complex (MHC)-I H-2Db and H-2Kb GL261-specific peptides27 (link) (CHI Scientific). IFN-γ was measured using a murine IFN-γ capture FluoroSpot kit (CTL) or mouse IFN-γ ELISpot Kit (R&D Systems). IFN-γ counts were evaluated in an ImmunoSpot S6 UNIVERSAL Analyzer (CTL) or S6 Ultimate-V Analyzer (CTL).